BACK

Nandhini Ravi

Nandhini Ravi

Vice President

Mumbai Office  |  nandhini.ravi@torreya.com   |   +91 22-6127-1191

Nandhini Ravi, a Vice President in Torreya’s Mumbai office, provides transaction support for companies across sectors in the healthcare industry in India.

Before joining Torreya’s team in 2016, Nandhini worked as an Analyst at IDFC’s investment banking division, and as a Management Associate with Citigroup.

She holds a B.Com. with Hons. in accountancy, audit, and taxation from the University of Delhi, and an M.B.A. in finance and strategy from the Indian Institute of Management, Trichy.

Nandhini is a chartered accountant.

Selected Transactions

Yapan Bio
Investment by
Piramal Pharma Solutions
December 2021
Hemmo
Sale of 100%
equity stake to
Piramal Pharma Solutions
$106 million + milestones
June 2021
Rubicon Research
Majority recap by
General Atlantic Partners
$125 million
April 2019
Biological-E
BE Vaccines SAS sale to Clean Cells, a portfolio company of
Archimed
Undisclosed
March 2019
Motilal Oswal
and
InvAscent
purchase of majority stake in
Symbiotec
undisclosed
December 2018
Neuland Laboratories
Sale of stake of
InvAscent
$35 million
Joint Sell-Side Advisor
May 2017
Rubicon Research
Sale of equity stake to
Everstone Group
$33 million
November 2016